Tarsus Pharmaceuticals, Inc. (TARS) › Total LiabilitiesTarsus Pharmaceuticals, Inc. (TARS) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2019: $919.0K2020: $5.99M2021: $12.18M2022: $34.96M2023: $68.50M2024: $152.46M2025: $218.73M$218.73M2019Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$218.73M+43.5%2024$152.46M+122.6%2023$68.50M+95.9%2022$34.96M+187.1%2021$12.18M+103.2%2020$5.99M+552.0%2019$919.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share